Legis Daily

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

USA119th CongressS-735| Senate 
| Updated: 2/26/2025
Tim Scott

Tim Scott

Republican Senator

South Carolina

Cosponsors (3)
Jon Ossoff (Democratic)Cory A. Booker (Democratic)Raphael G. Warnock (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill reauthorizes and significantly expands a federal demonstration program focused on sickle cell disease. It extends the program's funding through fiscal years 2025 to 2029 , substantially increasing the annual allocation from $4.455 million to $8.205 million . The legislation broadens the program's focus to explicitly include the prevention and treatment of complications of sickle cell disease , alongside the disease itself. It also diversifies the funding mechanisms, allowing for the use of grants and cooperative agreements in addition to contracts for program implementation. Furthermore, the bill includes a Sense of Congress emphasizing the need for continued research into the causes and cures for heritable blood disorders, including sickle cell disease.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 118-1852
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Bill from Previous Congress

S 115-2465
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Feb 26, 2025
Introduced in Senate
Feb 26, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 3, 2025

Latest Companion Bill Action

HR 119-1796
Introduced in House
  • Bill from Previous Congress

    S 118-1852
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023


  • Bill from Previous Congress

    S 115-2465
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018


  • February 26, 2025
    Introduced in Senate


  • February 26, 2025
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • March 3, 2025

    Latest Companion Bill Action

    HR 119-1796
    Introduced in House

Health

Related Bills

  • S 119-891: Bipartisan Health Care Act
  • HR 119-7148: Consolidated Appropriations Act, 2026
  • HR 119-1796: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
  • HR 119-1768: Lower Costs for Everyday Americans Act
Blood and blood diseasesGeneticsHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

USA119th CongressS-735| Senate 
| Updated: 2/26/2025
This bill reauthorizes and significantly expands a federal demonstration program focused on sickle cell disease. It extends the program's funding through fiscal years 2025 to 2029 , substantially increasing the annual allocation from $4.455 million to $8.205 million . The legislation broadens the program's focus to explicitly include the prevention and treatment of complications of sickle cell disease , alongside the disease itself. It also diversifies the funding mechanisms, allowing for the use of grants and cooperative agreements in addition to contracts for program implementation. Furthermore, the bill includes a Sense of Congress emphasizing the need for continued research into the causes and cures for heritable blood disorders, including sickle cell disease.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 118-1852
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Bill from Previous Congress

S 115-2465
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Feb 26, 2025
Introduced in Senate
Feb 26, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 3, 2025

Latest Companion Bill Action

HR 119-1796
Introduced in House
  • Bill from Previous Congress

    S 118-1852
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023


  • Bill from Previous Congress

    S 115-2465
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018


  • February 26, 2025
    Introduced in Senate


  • February 26, 2025
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • March 3, 2025

    Latest Companion Bill Action

    HR 119-1796
    Introduced in House
Tim Scott

Tim Scott

Republican Senator

South Carolina

Cosponsors (3)
Jon Ossoff (Democratic)Cory A. Booker (Democratic)Raphael G. Warnock (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • S 119-891: Bipartisan Health Care Act
  • HR 119-7148: Consolidated Appropriations Act, 2026
  • HR 119-1796: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
  • HR 119-1768: Lower Costs for Everyday Americans Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Blood and blood diseasesGeneticsHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding